Justin Earp

Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions

Joo Yeon Lee, Christine Garnett, Jogarao Gobburu et al. · Clinical Pharmacokinetics · 2011 · 146 citations

Drug Safety, Labelling Decisions, New Drug Approval +9

U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab

Steven J. Lemery, Jenny Zhang, Mark D. Rothmann et al. · Clinical Cancer Research · 2010 · 90 citations · Full text

Modeling Corticosteroid Effects in a Rat Model of Rheumatoid Arthritis I: Mechanistic Disease Progression Model for the Time Course of Collagen-Induced Arthritis in Lewis Rats

Justin Earp, Debra C. DuBois, Diana S. Molano et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 65 citations · Full text

Modeling Corticosteroid Effects in a Rat Model of Rheumatoid Arthritis II: Mechanistic Pharmacodynamic Model for Dexamethasone Effects in Lewis Rats with Collagen-Induced Arthritis

Justin Earp, Debra C. DuBois, Diana S. Molano et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 50 citations · Full text

Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration

Jane P. F. Bai, Justin Earp, Jeffry Florian et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 50 citations · Full text

Quantitative Pharmacology, System Pharmacology, Us Food +17